The effects of abaloparatide on acetabular bone mineral density and proximal femur strength in men with osteoporosis
{{output}}
Background: Abaloparatide treatment for 12 months led to significant and rapid increases in bone mineral density (BMD) in the lumbar spine, total hip, and femoral neck compared with placebo in the phase 3 ATOM study (NCT03512262)... ...
